Hamza Mohamed QabiL, A. Ramzy, M. Abdelmoneum, Khedr Ahmed Abd Elfattah
{"title":"新型口服抗凝剂治疗急性冠状动脉综合征的疗效评价","authors":"Hamza Mohamed QabiL, A. Ramzy, M. Abdelmoneum, Khedr Ahmed Abd Elfattah","doi":"10.7243/2052-4358-6-2","DOIUrl":null,"url":null,"abstract":"Abstract \nBackground: After an acute coronary syndrome(ACS), patients continue to be at risk of major adverse cardiovascular events (MACE) despite the standard treatment. The risk of MACE may be secondary to thrombin,","PeriodicalId":72522,"journal":{"name":"Cardiology & vascular research (Wilmington, Del.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessing the Efficacy of Novel Oral Anticoagulants after Acute Coronary Syndrome\",\"authors\":\"Hamza Mohamed QabiL, A. Ramzy, M. Abdelmoneum, Khedr Ahmed Abd Elfattah\",\"doi\":\"10.7243/2052-4358-6-2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract \\nBackground: After an acute coronary syndrome(ACS), patients continue to be at risk of major adverse cardiovascular events (MACE) despite the standard treatment. The risk of MACE may be secondary to thrombin,\",\"PeriodicalId\":72522,\"journal\":{\"name\":\"Cardiology & vascular research (Wilmington, Del.)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-08-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiology & vascular research (Wilmington, Del.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7243/2052-4358-6-2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology & vascular research (Wilmington, Del.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7243/2052-4358-6-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Assessing the Efficacy of Novel Oral Anticoagulants after Acute Coronary Syndrome
Abstract
Background: After an acute coronary syndrome(ACS), patients continue to be at risk of major adverse cardiovascular events (MACE) despite the standard treatment. The risk of MACE may be secondary to thrombin,
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
